China Biologic Products Holdings Inc (CBPO) Return on Assets ROA from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Biologic Products Holdings Inc   (NASDAQ: CBPO)


China Biologic Products Holdings Inc 's ROA from the fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is China Biologic Products Holdings Inc 's ROA in the fourth quarter of 2019?
China Biologic Products Holdings Inc achieved a return on average assets (ROA) of 7.8 % in its fourth quarter of 2019, which is below China Biologic Products Holdings Inc 's average return on assets, which stands at 19.69%.

ROA fell compared to the third quarter of 2019, despite the net income growth of % from the third quarter of 2019.

However, within the Healthcare sector 111 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2019 from to 801.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Total Assets Change 56.13 % -1.63 % -1.63 % -1.63 % 91.72 %
Y / Y Net Income Change 10.43 % - - - 79.93 %
Net Income (TTM) in million 163 148 148 148 148
Return On Assets (TTM) 7.8 % 7.94 % 7.9 % 7.87 % 7.84 %
CBPO's Total Ranking # 801 # # # # 1096
Total Assets (TTM) in million 2,565 1,938 1,938 1,938 1,643
Seq. Total Assets Change 32.36 % 0 % 0 % 17.96 % -16.61 %
Seq. Net Income Change - - - - -

CBPO's 5 Years Annual ROA >> Back to CBPO Management Effectiveness >> Compare CBPO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 10
Sector # 112
Overall # 778

Return On Assets Statistics
High Average Low
23.95 %
19.69 %
7.36 %
(Jun 30 2015)   (Dec 31 2018)





Financial Statements
China Biologic Products Holdings Inc 's Assets $ 2,565 million CBPO's Balance sheet
China Biologic Products Holdings Inc 's Income $ 163 million Quarterly CBPO's Income Statement
CBPO's Income by Division See CBPO's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 56.13 % 137.14 % 32.19 % 21.24 % 66.74 %
Total Assets in million 2,565 1,643 693 524 432
Y / Y Net Income Change 10.43 % 79.93 % -36.15 % 12.87 % 18.72 %
Net Income in million 163 148 82 129 114
Annual Return On Assets 6.37 % 9.01 % 11.87 % 24.58 % 26.4 %

CBPO's 5 Years Annual ROA >> Back to CBPO Management Effectiveness >> Compare CBPO ROA to its Competitors



Comment on CBPO's ROA in the fiscal year ending 2019
In the fiscal year 2019 ROA deteriorated to 6.37 %, despite annual net income growth of 10.43 % to $163.40 million, from $147.97 million a year ago, as CBPO's assets increase to $2,564.87 million, by 10.43 %.


More Return On Assets Ratios
CBPO's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CBPO's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CBPO's Competitors
Subscribers only: Roa for China Biologic Products Holdings Inc 's Suppliers
Subscribers only: Return On Assets for CBPO's Customers

You may also want to know
CBPO's Roi CBPO's Inventory Turnover Ratio CBPO's Growth Rates CBPO's Dividend Comparisons
CBPO's Profitability Ratios CBPO's Asset Turnover Ratio CBPO's Dividend Growth
CBPO's Roe CBPO's Valuation Ratios CBPO's Financial Strength Ratios CBPO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2019, within Healthcare Sector ROA
Lifevantage Corp  21.31 %
Waters Corporation  21.17 %
Biospecifics Technologies Corp  21.14 %
Aveo Pharmaceuticals Inc   21.03 %
Mettler toledo International Inc   20.93 %
Chemed Corporation  18.86 %
Align Technology inc   18.78 %
Exelixis Inc   18.73 %
Boston Scientific Corporation  18.17 %
Edwards Lifesciences Corporation  17.82 %
Alpha Pro Tech Ltd   17.68 %
Iradimed Corporation  16.01 %
Vertex Pharmaceuticals Inc  16.01 %
Alexion Pharmaceuticals Inc   15.78 %
Arrowhead Pharmaceuticals Inc   15.55 %
Intuitive Surgical Inc   15.51 %
Regeneron Pharmaceuticals Inc   15.45 %
Masimo Corp  15.33 %
Pro dex Inc   15.19 %
Fonar Corporation  15.01 %
Ac Immune Sa  14.79 %
Atrion Corporation  14.58 %
Castle Biosciences Inc   14.57 %
Horizon Therapeutics Public Limited Company  14.51 %
Incyte Corporation  14.48 %
Sinovac Biotech Ltd  14.42 %
Summit Therapeutics Inc   13.96 %
Utah Medical Products Inc  13.95 %
Illumina Inc   13.77 %
Zoetis Inc   13.43 %

Date modified: 2026-09-18T13:11:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.